LOW GRADE OVARIAN SEROUS ADENOCARCINOMA
Clinical trials for LOW GRADE OVARIAN SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOW GRADE OVARIAN SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOW GRADE OVARIAN SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new combo targets stubborn ovarian cancer
Disease control Recruiting nowThis study tests a combination of two drugs—nab-sirolimus and fulvestrant—in people whose low-grade serous ovarian cancer has returned. The goal is to see if the combo can shrink tumors or stop them from growing. About 37 adults with measurable disease will take part, and researc…
Matched conditions: LOW GRADE OVARIAN SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Researchers launch massive data collection to unlock secrets of Low-Grade ovarian cancer
Knowledge-focused Recruiting nowThis study is gathering information and tumor samples from 2,000 people with low-grade ovarian or peritoneal tumors. The goal is to create a detailed database that helps researchers learn more about these rare cancers and how they are treated. This knowledge may lead to better tr…
Matched conditions: LOW GRADE OVARIAN SEROUS ADENOCARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 05:08 UTC